Ashley Baker represents public and private company clients and private business owners in connection with a broad range of corporate transactional matters. Her practice focuses on advising clients in connection with their merger, acquisition and divestiture transactions; their joint venture and other strategic transactions; their corporate governance and formation matters; their contractual matters; and their general business and securities law counseling matters. Ms. Baker also represents clients in the preparation and negotiation of various commercial contracts, including supply agreements, services agreements, manufacturing agreements, distribution agreements, employment agreements, confidentiality agreements, non-competition agreements and licensing agreements. Ms. Baker has experience with companies in a number of different industries, including manufacturing, technology, life sciences, healthcare, consumer goods, private equity, executive office leasing and retail.

Professional Affiliations

    • American Bar Association
    • Bar Association of Metropolitan St. Louis
    • Bar Association of Metropolitan St. Louis
Read More

Representative Experience

  • Represented Emerson Electric Co. in connection with numerous acquisitions and divestitures in the United States, Europe and Canada
  • Represented Energizer Holdings, Inc. in its approximately $1.9 billion acquisition of the publicly-traded Playtex Products, Inc.
  • Represented TALX Corporation in connection with its $1.4 billion public company merger transaction with Equifax Inc.
  • Represented owners of Cejon, Inc. in sale to Steven Madden Ltd., a Nasdaq-listed retailer of footwear and fashion handbags and accessories
  • Represented Sigma-Aldrich Corporation in connection with various acquisitions
  • Represented national systems integration corporation in the negotiation of multiple multi-year services, equipment purchase and software agreements
  • Served as outside counsel for publicly-traded company with respect to commercial transactions
  • Represented biotech company in numerous investments in start-up companies